Literature DB >> 23146428

Prognostic values of multichannel intraluminal impedance and pH monitoring in newborns with symptoms of gastroesophageal reflux disease.

Francesco Cresi1, Emanuela Locatelli, Cristina Marinaccio, Giulia Grasso, Alessandra Coscia, Enrico Bertino.   

Abstract

OBJECTIVE: To evaluate the relationship between multichannel intraluminal impedance and pH monitoring (MII/pH) values in newborns with symptoms of gastroesophageal reflux disease (GERD) and clinical history in their first 3 years of life. STUDY
DESIGN: Sixty-four newborns with GERD symptoms who underwent MII/pH in the first weeks of life were enrolled into a clinical follow-up program. Follow-up visits were programmed at 1, 3, 6, 9, 12, 18, 24, and 36 months. Patients were divided into 3 groups according to duration of symptoms: short (1-3 months), medium (4-9 months), and long (>9 months), and MII/pH values in these groups were compared.
RESULTS: Fifty-three patients completed the 3-year follow-up. The number of patients with GERD symptoms decreased each month. A comparison of MII/pH values of the 3 lifetime symptom groups revealed differences in the impedance bolus exposure index (F = 83; P = .012) and proximal reflux frequency (F = 410; P = .022). These 2 MII variables showed an increasing trend from the short lifetime symptom group to the long lifetime symptom group. Weakly acidic reflux events, but not acidic events, were responsible for these differences.
CONCLUSION: MII/pH in newborns has prognostic value regarding the duration of GERD symptoms and provides useful information that clinicians may give parents about the prognosis of symptomatic infants. Impedance bolus exposure index and proximal reflux frequency seem to be the variables with the highest predictive value. Weakly acidic reflux events play an important role in determining the duration of GERD symptoms in newborns.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23146428     DOI: 10.1016/j.jpeds.2012.10.009

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Nutritional adequacy of a novel human milk fortifier from donkey milk in feeding preterm infants: study protocol of a randomized controlled clinical trial.

Authors:  Alessandra Coscia; Enrico Bertino; Paola Tonetto; Chiara Peila; Francesco Cresi; Sertac Arslanoglu; Guido E Moro; Elena Spada; Silvano Milani; Marzia Giribaldi; Sara Antoniazzi; Amedeo Conti; Laura Cavallarin
Journal:  Nutr J       Date:  2018-01-09       Impact factor: 3.271

2.  Multichannel Intraluminal Impedance and pH Monitoring: A Step Towards Pediatric Reference Values.

Authors:  Francesco Cresi; Elena Andrea Cester; Silvia Salvatore; Domenico Umberto De Rose; Antonio Ripepi; Anna Maria Magistà; Claudia Fontana; Elena Maggiora; Alessandra Coscia; Ruggiero Francavilla; Fernanda Cristofori
Journal:  J Neurogastroenterol Motil       Date:  2020-07-30       Impact factor: 4.924

3.  Effects on Gastroesophageal Reflux of Donkey Milk-Derived Human Milk Fortifier Versus Standard Fortifier in Preterm Newborns: Additional Data from the FortiLat Study.

Authors:  Francesco Cresi; Elena Maggiora; Alice Pirra; Paola Tonetto; Carlotta Rubino; Laura Cavallarin; Marzia Giribaldi; Guido E Moro; Chiara Peila; Alessandra Coscia
Journal:  Nutrients       Date:  2020-07-18       Impact factor: 5.717

4.  Esophageal Bolus Transit in Newborns with Gastroesophageal Reflux Disease Symptoms: A Multichannel Intraluminal Impedance Study.

Authors:  Francesco Cresi; Stefania Alfonsina Liguori; Elena Maggiora; Emanuela Locatelli; Flavia Indrio; Enrico Bertino; Alessandra Coscia
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.